Empagliflozina Pentafarma

Empagliflozin by Pentafarma is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which help the kidneys remove excess glucose from the body.

Empagliflozin is primarily used to lower blood sugar levels in adults with type 2 diabetes. It works by helping the kidneys remove excess glucose from the body, which can be beneficial for managing blood sugar levels. This medication is often used as part of a comprehensive treatment plan that includes diet and exercise. Empagliflozin may also be used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Common effects of Empagliflozin may include increased urination, which is a result of the medication's mechanism of action. Some individuals may also experience symptoms such as dehydration, dizziness, or lightheadedness. It is important to stay hydrated while taking this medication to help mitigate these effects.

Empagliflozin should be handled with care, especially for individuals with certain medical conditions. It is important to inform your healthcare provider about any existing health issues, particularly kidney problems, as this medication can affect kidney function. Regular monitoring of blood sugar levels and kidney function is recommended while using Empagliflozin.

Empagliflozin may interact with other medications, including insulin and other diabetes drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels and increase the risk of dehydration.